UK Regenerative Medicine Platform

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:Research_Institute
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:MRC_Centre_for_Regenerative_Medicine
gptkbp:addresses ethical considerations
healthcare challenges
gptkbp:advocates_for regenerative medicine policies
gptkbp:aims_to improve patient outcomes
reduce time to market
foster innovation
increase awareness
enhance collaboration
enhance public understanding
enhance research quality
increase funding
build capacity
accelerate research
improve collaboration
support commercialization
translate discoveries into therapies
gptkbp:analyzes cell therapies
gptkbp:collaborates_with academic institutions
industry partners
gptkbp:conducts research projects
gptkbp:contributed_to scientific knowledge
gptkbp:develops biomaterials
regenerative therapies
gptkbp:encourages innovation
knowledge sharing
gptkbp:engages_in stakeholders
international partnerships
gptkbp:established gptkb:2017
gptkbp:explores gene therapies
gptkbp:facilitates networking opportunities
technology transfer
gptkbp:focuses_on regenerative medicine
gptkbp:fosters public-private partnerships
https://www.w3.org/2000/01/rdf-schema#label UK Regenerative Medicine Platform
gptkbp:involves multidisciplinary teams
gptkbp:operates_in gptkb:United_Kingdom
gptkbp:organizes conferences
gptkbp:promotes public engagement
sustainable practices
best practices
gptkbp:provides resources for researchers
training opportunities
clinical resources
gptkbp:publishes research findings
gptkbp:receives_funding_from gptkb:government_agency
gptkbp:research tissue engineering
gptkbp:supports clinical trials
startups
patient advocacy groups
research collaborations
gptkbp:utilizes advanced technologies
gptkbp:works_with regulatory bodies